Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection – Medscape
Medscape |
Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection
Medscape In allogeneic HSCTs, stem cells are derived from another person's bone marrow, as opposed to the patient's own. The FDA puts the number of allogeneic HSCTs performed each year at more than 27,000 worldwide; roughly 8500 are performed each year in … Prevymis Approved to Prevent Virus in Patients Receiving Stem Cell Transplants FDA Approves Prevymis to Prevent CMV Among Stem Cell Transplant Patients |
